# Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease

> **NCT03007238** · PHASE2 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Chronic Graft Versus Host Disease

## Interventions

- **BIOLOGICAL:** Aldesleukin
- **PROCEDURE:** Extracorporeal Photopheresis
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Quality-of-Life Assessment

## Key facts

- **NCT ID:** NCT03007238
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-18
- **Primary completion:** 2018-10-16
- **Final completion:** 2019-06-26
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03007238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03007238, "Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03007238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*